Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma

Melinda Y Chang, Mitchell Kamrava, D. Jeffrey Demanes, Min Leu, Nzhde Agazaryan, James Lamb, Joel N. Moral, Robert Almanzor, Tara A. McCannel

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Purpose: To report intraoperative ultrasonography-guided positioning of iodine 125 (I 125) plaques for brachytherapy of choroidal melanoma as a quality improvement measure. Design: Retrospective, single-center, consecutive case-cohort study. Participants: One hundred fifty consecutive patients with choroidal melanoma. Methods: Patients with choroidal melanoma who were treated with I 125 plaque brachytherapy from January 2007 through January 2011 with at least 6 months of clinical follow-up were included. Main Outcome Measures: Patient and tumor characteristics at diagnosis were tabulated. The need for plaque repositioning if intraoperative ultrasonography showed the plaque to be either not centered on the tumor or if there was less than 1.0 mm of plaque margin beyond the tumor border was recorded. The rate of local treatment failure and occurrence of distant metastasis were determined. Results: The average interval from surgery to last follow-up was 21.5 months. Fifty-four (36%) of 150 patients required plaque repositioning. Of tumors located in the macula, equator, and periphery, 15 (36.6%), 26 (36.6%), and 13 (34.2%) required repositioning. There was no case of local treatment failure during a mean follow-up of 21.5 months (range, 6-48 months). Clinical evidence of choroidal melanoma metastasis developed in 9 patients. The cumulative 2-year Kaplan-Meier rate of local treatment failure in the cohort was statistically lower compared with the Collaborative Ocular Melanoma Study, which did not require ultrasonography-guided plaque positioning. Conclusions: Intraoperative ultrasonography identified the need to reposition I 125 plaques to achieve centration and plaque margin (>1.0 mm) beyond the tumor border in 36% of eyes. Neither tumor size nor tumor location correlated with the need to reposition the plaque. There was no case of local treatment failure during follow-up in this series. Correct plaque position is an essential component of quality outcomes in brachytherapy. Intraoperative ultrasonography reduces geographic errors in placement in eye plaque therapy and may help to reduce local treatment failure in choroidal melanoma. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

Original languageEnglish (US)
Pages (from-to)1073-1077
Number of pages5
JournalOphthalmology
Volume119
Issue number5
DOIs
StatePublished - May 1 2012

Fingerprint

Brachytherapy
Iodine
Melanoma
Ultrasonography
Treatment Failure
Neoplasms
Therapeutics
Neoplasm Metastasis
Disclosure
Quality Improvement
Cohort Studies
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma. / Chang, Melinda Y; Kamrava, Mitchell; Demanes, D. Jeffrey; Leu, Min; Agazaryan, Nzhde; Lamb, James; Moral, Joel N.; Almanzor, Robert; McCannel, Tara A.

In: Ophthalmology, Vol. 119, No. 5, 01.05.2012, p. 1073-1077.

Research output: Contribution to journalArticle

Chang, MY, Kamrava, M, Demanes, DJ, Leu, M, Agazaryan, N, Lamb, J, Moral, JN, Almanzor, R & McCannel, TA 2012, 'Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma', Ophthalmology, vol. 119, no. 5, pp. 1073-1077. https://doi.org/10.1016/j.ophtha.2011.11.011
Chang, Melinda Y ; Kamrava, Mitchell ; Demanes, D. Jeffrey ; Leu, Min ; Agazaryan, Nzhde ; Lamb, James ; Moral, Joel N. ; Almanzor, Robert ; McCannel, Tara A. / Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma. In: Ophthalmology. 2012 ; Vol. 119, No. 5. pp. 1073-1077.
@article{321fbf60db2a42249d8109942c965873,
title = "Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma",
abstract = "Purpose: To report intraoperative ultrasonography-guided positioning of iodine 125 (I 125) plaques for brachytherapy of choroidal melanoma as a quality improvement measure. Design: Retrospective, single-center, consecutive case-cohort study. Participants: One hundred fifty consecutive patients with choroidal melanoma. Methods: Patients with choroidal melanoma who were treated with I 125 plaque brachytherapy from January 2007 through January 2011 with at least 6 months of clinical follow-up were included. Main Outcome Measures: Patient and tumor characteristics at diagnosis were tabulated. The need for plaque repositioning if intraoperative ultrasonography showed the plaque to be either not centered on the tumor or if there was less than 1.0 mm of plaque margin beyond the tumor border was recorded. The rate of local treatment failure and occurrence of distant metastasis were determined. Results: The average interval from surgery to last follow-up was 21.5 months. Fifty-four (36{\%}) of 150 patients required plaque repositioning. Of tumors located in the macula, equator, and periphery, 15 (36.6{\%}), 26 (36.6{\%}), and 13 (34.2{\%}) required repositioning. There was no case of local treatment failure during a mean follow-up of 21.5 months (range, 6-48 months). Clinical evidence of choroidal melanoma metastasis developed in 9 patients. The cumulative 2-year Kaplan-Meier rate of local treatment failure in the cohort was statistically lower compared with the Collaborative Ocular Melanoma Study, which did not require ultrasonography-guided plaque positioning. Conclusions: Intraoperative ultrasonography identified the need to reposition I 125 plaques to achieve centration and plaque margin (>1.0 mm) beyond the tumor border in 36{\%} of eyes. Neither tumor size nor tumor location correlated with the need to reposition the plaque. There was no case of local treatment failure during follow-up in this series. Correct plaque position is an essential component of quality outcomes in brachytherapy. Intraoperative ultrasonography reduces geographic errors in placement in eye plaque therapy and may help to reduce local treatment failure in choroidal melanoma. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.",
author = "Chang, {Melinda Y} and Mitchell Kamrava and Demanes, {D. Jeffrey} and Min Leu and Nzhde Agazaryan and James Lamb and Moral, {Joel N.} and Robert Almanzor and McCannel, {Tara A.}",
year = "2012",
month = "5",
day = "1",
doi = "10.1016/j.ophtha.2011.11.011",
language = "English (US)",
volume = "119",
pages = "1073--1077",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Intraoperative ultrasonography-guided positioning of iodine 125 plaque brachytherapy in the treatment of choroidal melanoma

AU - Chang, Melinda Y

AU - Kamrava, Mitchell

AU - Demanes, D. Jeffrey

AU - Leu, Min

AU - Agazaryan, Nzhde

AU - Lamb, James

AU - Moral, Joel N.

AU - Almanzor, Robert

AU - McCannel, Tara A.

PY - 2012/5/1

Y1 - 2012/5/1

N2 - Purpose: To report intraoperative ultrasonography-guided positioning of iodine 125 (I 125) plaques for brachytherapy of choroidal melanoma as a quality improvement measure. Design: Retrospective, single-center, consecutive case-cohort study. Participants: One hundred fifty consecutive patients with choroidal melanoma. Methods: Patients with choroidal melanoma who were treated with I 125 plaque brachytherapy from January 2007 through January 2011 with at least 6 months of clinical follow-up were included. Main Outcome Measures: Patient and tumor characteristics at diagnosis were tabulated. The need for plaque repositioning if intraoperative ultrasonography showed the plaque to be either not centered on the tumor or if there was less than 1.0 mm of plaque margin beyond the tumor border was recorded. The rate of local treatment failure and occurrence of distant metastasis were determined. Results: The average interval from surgery to last follow-up was 21.5 months. Fifty-four (36%) of 150 patients required plaque repositioning. Of tumors located in the macula, equator, and periphery, 15 (36.6%), 26 (36.6%), and 13 (34.2%) required repositioning. There was no case of local treatment failure during a mean follow-up of 21.5 months (range, 6-48 months). Clinical evidence of choroidal melanoma metastasis developed in 9 patients. The cumulative 2-year Kaplan-Meier rate of local treatment failure in the cohort was statistically lower compared with the Collaborative Ocular Melanoma Study, which did not require ultrasonography-guided plaque positioning. Conclusions: Intraoperative ultrasonography identified the need to reposition I 125 plaques to achieve centration and plaque margin (>1.0 mm) beyond the tumor border in 36% of eyes. Neither tumor size nor tumor location correlated with the need to reposition the plaque. There was no case of local treatment failure during follow-up in this series. Correct plaque position is an essential component of quality outcomes in brachytherapy. Intraoperative ultrasonography reduces geographic errors in placement in eye plaque therapy and may help to reduce local treatment failure in choroidal melanoma. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

AB - Purpose: To report intraoperative ultrasonography-guided positioning of iodine 125 (I 125) plaques for brachytherapy of choroidal melanoma as a quality improvement measure. Design: Retrospective, single-center, consecutive case-cohort study. Participants: One hundred fifty consecutive patients with choroidal melanoma. Methods: Patients with choroidal melanoma who were treated with I 125 plaque brachytherapy from January 2007 through January 2011 with at least 6 months of clinical follow-up were included. Main Outcome Measures: Patient and tumor characteristics at diagnosis were tabulated. The need for plaque repositioning if intraoperative ultrasonography showed the plaque to be either not centered on the tumor or if there was less than 1.0 mm of plaque margin beyond the tumor border was recorded. The rate of local treatment failure and occurrence of distant metastasis were determined. Results: The average interval from surgery to last follow-up was 21.5 months. Fifty-four (36%) of 150 patients required plaque repositioning. Of tumors located in the macula, equator, and periphery, 15 (36.6%), 26 (36.6%), and 13 (34.2%) required repositioning. There was no case of local treatment failure during a mean follow-up of 21.5 months (range, 6-48 months). Clinical evidence of choroidal melanoma metastasis developed in 9 patients. The cumulative 2-year Kaplan-Meier rate of local treatment failure in the cohort was statistically lower compared with the Collaborative Ocular Melanoma Study, which did not require ultrasonography-guided plaque positioning. Conclusions: Intraoperative ultrasonography identified the need to reposition I 125 plaques to achieve centration and plaque margin (>1.0 mm) beyond the tumor border in 36% of eyes. Neither tumor size nor tumor location correlated with the need to reposition the plaque. There was no case of local treatment failure during follow-up in this series. Correct plaque position is an essential component of quality outcomes in brachytherapy. Intraoperative ultrasonography reduces geographic errors in placement in eye plaque therapy and may help to reduce local treatment failure in choroidal melanoma. Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.

UR - http://www.scopus.com/inward/record.url?scp=84860434033&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84860434033&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2011.11.011

DO - 10.1016/j.ophtha.2011.11.011

M3 - Article

VL - 119

SP - 1073

EP - 1077

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 5

ER -